Suppr超能文献

大鼠中正常异体输血的抗肿瘤免疫

Anti-tumour immunity by normal allogeneic blood transfusion in rat.

作者信息

Oikawa T, Hosokawa M, Imamura M, Sendo F, Nakayama M

出版信息

Clin Exp Immunol. 1977 Mar;27(3):549-54.

Abstract

Growth of transplantable KMT-17 tumour in syngeneic WKA/MK rats was inhibited by i.v. preimmunization with whole blood from normal rats of allogeneic strains. The inhibitory effect was also observed in rats immunized with allogeneic white blood cells alone. The strength of the inhibitory effect mainly depended on the the strain of donor rat used; blood from Donryu and Kyoto strain rats produced the strongest inhibition, blood from Tokyo and Fischer strain rats produced moderate inhibition to the syngeneic tumour growth. Blood from ACI/N strain rats did not produce the inhibition. The mechanism of blood transfusion in inhibiting tumour growth is not yet clear. However, it seems that GVH reaction does not play an important role in the mechanism of the inhibition effect, because the effect was obtained by immunization with mitomycin C-treated allogeneic white blood cells and also by the immunization effect may be due to nonspecific active immunization. Significance of blood transfusion with special reference to clinical immunogtherapy of cancer is discussed.

摘要

用同种异体品系正常大鼠的全血进行静脉预免疫,可抑制同基因WKA/MK大鼠体内可移植性KMT - 17肿瘤的生长。在用同种异体白细胞单独免疫的大鼠中也观察到了这种抑制作用。抑制作用的强度主要取决于所用供体大鼠的品系;来自Donryu和京都品系大鼠的血液产生的抑制作用最强,来自东京和Fischer品系大鼠的血液对同基因肿瘤生长产生中等程度的抑制作用。来自ACI/N品系大鼠的血液未产生抑制作用。输血抑制肿瘤生长的机制尚不清楚。然而,移植物抗宿主反应(GVH反应)似乎在抑制作用机制中不起重要作用,因为用丝裂霉素C处理的同种异体白细胞免疫可获得这种效果,而且这种免疫效果可能归因于非特异性主动免疫。本文讨论了输血的意义,特别提及了癌症临床免疫治疗。

引用本文的文献

1
Modulation of tumor growth by allogeneic blood transfusion.
J Cancer Res Clin Oncol. 1986;111(1):50-3. doi: 10.1007/BF00402776.
3
The effects of blood transfusion on the prognosis of patients with gastric cancer.
World J Surg. 1989 Sep-Oct;13(5):637-43. doi: 10.1007/BF01658891.
4
Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice.
J Cancer Res Clin Oncol. 1992;118(3):176-80. doi: 10.1007/BF01410130.

本文引用的文献

2
PRELIMINARY OBSERVATIONS ON TREATMENT OF ADVANCED CANCER BY INJECTION OF ALLOGENEIC SPLEEN CELLS.
Lancet. 1963 Aug 31;2(7305):426-9. doi: 10.1016/s0140-6736(63)92171-8.
3
Clinical immunologic study of malignant disease: response to tumor transplants and transfer of leukocytes.
Ann Surg. 1966 Sep;164(3):482-90. doi: 10.1097/00000658-196609000-00011.
5
Immunotherapy of malignant disease.
Arch Surg. 1969 Sep;99(3):376-81. doi: 10.1001/archsurg.1969.01340150084016.
7
Experiences with lymphocyte immunotherapy in experimental tumor systems.
Cancer. 1971 Apr;27(4):771-81. doi: 10.1002/1097-0142(197104)27:4<771::aid-cncr2820270404>3.0.co;2-t.
8
Cross-immunity among syngeneic tumors of mice.
Tohoku J Exp Med. 1972 Sep;108(1):79-84. doi: 10.1620/tjem.108.79.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验